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The objective of this qualitative study was to explore the factors that influence 
community dwelling older adults in deciding to take or not take the seasonal 
influenza vaccine. Thirty-one receivers and six non-receivers (aged 67-91 years) 
living in assisted and unassisted urban residences participated in six focus 
groups in London, Ontario. Informed by van Manen’s phenomenological r 
approach, an inductive content analysis was performed to analyze the transcripts 
from focus groups. The major facilitators of taking the vaccine were the 
recommendation by and trust in health professionals, and a belief in vaccine 
efficacy. The major barriers were a fear of adverse reactions anct the belief in 
resilience of an older adult. The decision-making process regarding seasonal 
influenza vaccination is now better understood in older adults and can,easily be 
fit within the conceptual framework of the Health Belief Model.
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Seasonal influenza, more commonly known as the ‘flu’, Is an Infection of 
the airways caused by various influenza viral strains (Butler-Jones, 2008). It is 
more than just an inconvenience; it can have severe, even fatal consequences. 
Approximately 15-20% of Canadians develop the infection per year (Statistics 
Canada, 2008). Despite being preventable, between 4,000 and 8,000 Canadians 
die every year from influenza and its complications (Canadian Coalition for 
Immunization Awareness and Promotion, 2009). The acute respiratory infection 
is caused by one of three viral types -  A, B, or C. These are further divided into 
subtypes based on their chemical surface proteins (International Committee on 
Taxonomy of Viruses, 2006). Type A and type B viral strains are much more 
common than type C strains; hence, seasonal influenza vaccinations do not 
incorporate the type C viral strain. Currently, H1N1 and H3N2 (both type A viral 
strains) are circulating throughout the human population in the greatest 
frequency (World Health Organization [WHO], 2009). Symptoms begin after the 
virus incubates for two days inside lung epithelium. Influenza is characterized by 
sudden onset of fever, headache, cough, sore throat, running nose and overall 
malaise (Butler-Jones, 2008).
Although many of these symptoms are tiresome, they are manageable 
and most people recover within one week. The disease can be more harmful to 
high risk individuals in the population. “High risk individuals are those most 
susceptible to further complications and include children under the age of two,
1 INTRODUCTION
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adults over the age of 65 and people of any age with medical conditions such as 
asthma, chronic heart, lung or kidney disease, and weakened immune systems 
(WHO, 2009). Seasonal influenza can spread rapidly throughout the population 
by direct inhalation of viral droplets (viral particles contained by saliva) or by 
direct contact with viral particles. In most developed countries, anti-viral drugs 
may be distributed by a physician to combat infection; however, this is usually 
only done in special circumstances to prevent outbreaks in institutions and must 
be given within 24-48 hours of the onset of symptoms. Many of these are limited 
in their capacity to fight infection as viruses are capable of developing resistance 
by changing their genetic material. Anti-viral medications are not meant to 
replace taking the vaccine (Centers for Disease Control and Prevention, 2011). 
The World Health Organization (2009) and the Public Health Agency of Canada 
(2008) monitor viral circulation and antiviral susceptibility throughout the year. 
The influenza epidemic in Canada frequently peaks during the cool autumn and 
winter months resulting in many hospitalizations and deaths.
Hospitalizations and deaths have prime importance for the Canadian 
economy. Statistics Canada (2008) reported that between 70,000 and 75,000 
hospitalization admissions in 2008 were for influenza complications alone. 
Jefferson, Wegmuller and Ward (1999) reported that employees lose up to 80% 
of their work hours within the first seven days of disease onset and that the total 
cost of influenza in Canada is approximately $ 1 billion per year accounting for 
both productivity loss and health care cost. i
Seasonal influenza Is highly preventable. The most effective way to 
protect one from contracting the disease is to receive the seasonal influenza 
vaccination which contains an inactivated (killed) form of the virus. The 
inactivated virus within the vaccine elicits an immune response in the body. This 
allows the immune system to better defend the body should that same virus 
present itself again in the future (WHO, 2009). Vaccine manufacturing and 
delivering began in the 1950s and was widely accepted and administered to the 
Canadian public by the 1970s (Hilleman, 2000). Physicians recommend getting 
the vaccine before December in order to ensure the longest protective coverage 
and to avoid missing influenza season altogether (Centers for Disease Control 
and Prevention, 2011). The vaccine can prevent between 70% and 90% of 
influenza-specific illness if the correct viral strains are chosen for inclusion in the 
vaccine (WHO, 2009). .
In industrialized countries, 90% of deaths caused by influenza occur in the 
elderly, a segment of the population belonging to a high risk group. Multiple 
studies have shown that the vaccine is highly effective in preventing severe 
influenza by up to 60% and death by influenza by up to 80%, specifically in older 
adults (Dean, Moffatt, Rosewell, Dwyer, Lindley, Booy, & MacIntyre, 2010; 
Fedson, Wajda, Nicol, Hammond, Kaiser, & Roos, 1993; Nichol, Margolis, 
Wuorenma & Von Sternberg, 1994). The vaccine is less effective (30-40%) in 
nursing home residents who are quite frail and have compromised immune 
systems. However, the vaccine is still beneficial to them in that it reduces severe 
influenza-related hospitalizations by up to 50-60% (Centers for Disease Control
3
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and Prevention, 2011). Despite this strong evidence from research, on average, 
35% of Canadian elderly individuals from this high risk group still fail to receive 
their annual vaccination (Statistics Canada, 2008). In London, Ontario, , 
specifically, 76.3% of elderly individuals receive the seasonal influenza vaccine 
(Statistics Canada, 2009).
There is some risk associated with taking the seasonal influenza vaccine 
as side:effects have been reported. According to the Centers for Disease Control 
and Prevention (2011) side-effects may.include soreness, redness, or swelling 
where the vaccine was given, a low grade fever, or body aches. Side-effects 
usually occur between one and two days after the.vaccine has been given. 
Certain rare conditions have been reported following immunization. Life- 
threatening allergic reactions are rare but may include breathing problems, hives, 
paleness, or weakness (Centers for Disease Control and Prevention, 2011). 
Finally, an extremely rare condition called Guillain-Barre syndrome may develop 
which causes nerve damage and muscle weakness. Approximately one person 
per 100,000 develops this illness per year (Centers for Disease Control and 
Prevention, 2011). There is a national surveillance system in place in Canada for 
the reporting of adverse events attributable to the seasonal influenza vaccine.
The immune system is one of the first systems to decline as a person gets 
older. Older adults have a greater, risk of developing infections with a reduced 
ability to fight off disease compared to individuals younger than 65 years. 
Malnutrition and depression can exacerbate this decline in immunity (Ferrini & 
Ferrini, 2008). It is important to consider the lives of elders since the Canadian
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population experiences yearly influenza epidemics. In Canada, it is 
recommended that all individuals over the age of 65 receive the seasonal 
influenza vaccine (National Advisory Committee on Immunization, 2010). The 
universal vaccination program, offered in Ontario since 2000, allows individuals 
to receive the vaccine free of charge in a variety of settings including doctors’ 
offices, employer-sponsored clinics, public health units, local pharmacies, 
hospitals, long-term care homes, Family Health Teams, Community Health 
Centres, and Community Care Access Centres (National Post, 2006). According 
to the Institute for Clinical Evaluative Sciences [ICES] (2007), a national 
consensus conference on influenza in 1993 set a target for seasonal influenza 
vaccination coverage at 70% for adults aged 65 or older; this target was not fully 
met by 2005. The national target was raised again in 2005 to 80% (ICES, 2007). 
Despite this new target, vaccination rates for most high risk individuals still fall 
short of national targets (Kwong, Sambell, Johansen, Stukel, & Manuel, 2006). In 
2008, only a moderate increase in compliance was found with 66.5% of the 
elderly Canadian population (aged 65 years and older) receiving the seasonal 
influenza vaccine (Statistics Canada, 2009a). Although the Canadian 
government is attempting to achieve higher compliance by increasing targets, 
Canadian public health researchers Kwong, Rosella and Johansen (2010) report 
that not enough individuals who are considered high risk are getting the shot. 
Given the rapidly aging Canadian population, current elderly vaccine coverage 
rates are a cause for concern. Peter Hotez, a George Washington University 
microbiologist and president of Sabin Vaccine Institute, argues that influenza
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epidemics have the greatest effect on the poorest people in the country, many of 
whom are elderly (Mooney, 2009).
1.1 Theoretical Models
To determine which facilitators and barriers exist for elderly individuals 
when choosing to receive or not receive the influenza vaccination, the decision­
making process must be understood. Most of the research to date has been 
conducted in Europe and Australia and is grounded in two pervasive theories: the 
Theory of Planned Behaviour (TPB), and the Health Belief Model (HBM). 
Although there are variations of these two theories, TPB and HBM are very 
commonly used to understand the decision-making process for preventative 
health behaviours (Shumaker, Ockene, & Riekert, 2009). An additional theory 
which is less commonly used is Life Course Theory (LCT), which may also be 
used to study decision-making.
Ajzen and Fishbein (1980) developed the Theory of Planned Behaviour 
which seeks to understand how an individual’s behaviour can be changed. The 
authors contend that since volitional behaviour is deliberate and planned, TPB 
can predict this behaviour which can then be modified. According to this theory, 
human action is directed by three constructs: (1) Behaviour Beliefs - beliefs about 
behavioural outcomes or consequences, (2) Normative Beliefs -  beliefs about 
normative expectations of others, and (3) Perceived Control- beliefs about 
factors that facilitate or impede behaviour. These constructs are critical when 
designing programs which aim to change individuals’ behaviour. Together these 
three constructs form a “behavioural intention.” Ajzen and Fishbein (1980)
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indicate that the more favorable the individual’s attitude, and the greater the 
social pressure and perceived control, the stronger should be the person’s 
intention to perform the behaviour in question. As an example, Figure1-1 is a 
schematic representation of how this theory could explain the behaviour of an 
individual who may or may not obtain the seasonal influenza vaccination. The 
TPB is limited in that it does not take into consideration the influence of 
economics, though this might play a role in behaviour modification.
8
Behavioural Beliefs Normative Beliefs Perceived Control
Beliefs about behavioural ■ ^®li®fs about normative Beliefs about the factors that
outcomes or expectation of others facilitate or impede behaviour
consequences .. r My dodor told me the
Vaccines will/will not prevent 
me from getting sick
vaccine is effective and that I 
should get it.
My family does not believe in 
getting vaccines
I can choose to take or not take the 
vaccine
Behavioural Intention ► Behaviour
Figure 1-1. Conceptual framework for the Theory of Planned Behaviour using 
seasonal influenza vaccination as an example.
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The Health Belief Model was developed in the 1950s by social 
psychologists at the American Public Health Service. Originally the model was 
offered by Hoffbaum In 1958, but has since been expanded and revised by many 
authors (Janz, Champion, & Stretcher, 2002). The primary focus of the model 
centres on the attitudes and beliefs an individual possesses. The HBM has been 
used to understand a range of short-term and.long-term health behaviour risks 
such as sexuality and HIV/AIDS, and smoking. In The Historical Origins of the 
Health Belief Model (1974), Rosenstock describes six constructs which provide 
the theoretical framework for the HBM: (1) Perceived Susceptibility relates to 
one’s own opinion of contracting the illness; (2) Perceived Severity is one’s 
opinion of how dangerous the illness and its consequences could'be; (3) 
Perceived Benefits is one’s opinion on the efficacy of advised action; (4) 
Perceived Barriers relates to one’s opinion of the physical and psychological 
costs associated with the advised action; (5) Cues To Action are strategies used 
to promote the advised action (e.g., mass media, family or friend advice); and (6) 
Modifying Factors are intrinsic variables to the individual guiding their self- 
efficacy in seeking out the recommended health measure (e.g., socio­
demographic variables, knowledge of disease). In combination, these six 
constructs form the individual’s Perceived Threat of Disease which prepares an 
individual for action (Rosenstock, 1974). Figure 1-2 diagrams a schematic 















Figure 1-2. Conceptual framework for the Health Belief Model; adapted from 
Nutbeam and Harris (1998).
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Decision-making may be thought of as an individualized process that can 
be influenced by many constructs. An additional theory in studying decision­
making is Life Course Theory (LCT), also known as the Life Course Perspective, 
which makes a powerful connection between individuals’ lives and the historical 
and socioeconomic context from which their lives unfold. ‘Life course’ can be 
defined as a sequence of socially defined events and roles enacted by an 
individual over time (Giele & Elder, 1998). One must differentiate between ‘life 
course’ and ‘life cycle’ with the former pertaining to a set of social events and the 
latter to biologically determined events.
According to Giele and Elder (1998), the key elements of Life Course 
Theory include (1) socio-historical and geographical location; (2) timing of lives; 
(3) variability; (4) linked lives; (5) human agency; and (6) how the past shapes 
the future. Socio-historical and geographical location identifies how an individual 
could be transformed by the unique social events that occurred in their lifetime 
and also by the distinct geographical disposition in which that person lives. Price, 
McKenry, and Murphy (2000) assert that timing of lives can be broken down into 
three constructs. Individual time relates to chronological age. Generational time 
represents a cohort of individuals based primarily on their age; for example, the 
baby boom generation. Historical time relates to a series of individuals grouped 
together because of the shared experience of some large social phenomena, for 
example, living through the Second World War. The timing of a discrete life 
change can increase or decrease the chance of a particular life trajectory. 
Variability relates to the difference in perspectives among individuals from the
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same age cohort. Riley (1987) discredits the notion that all members of an age 
cohort share identical perspectives regarding particular social phenomena. 
Cohorts may have similar gender, class, or ethnicity characteristics but they are 
by no means homogenous. Linked lives maintains that individual lives are 
interconnected; the macro processes that occur in society have the opportunity to 
resonate between a network of shared relationships even if only indirectly.
Human agency refers to the ability of an individual to make active, yet thoughtful 
and self-controlled decisions based on social structure (Clausen, 1991). Finally, 
the past has the potential to affect the future, and can be described as a domino 
effect. Earlier events in life can produce a chain of reactions leading to particular 
outcomes in the future. Life Course Theory may help understand one’s decision­
making process by the following example. Many older adults today are baby 
boomers and lived through periods of history when disease epidemics were 
common. These past historical experiences may have shaped or influenced their 
decision to receive a disease-preventative vaccine today.
\
The aim of this project was to analyze individual accounts of decision­
making with regard to the receipt of the seasonal influenza vaccine. The Theory 
of Planned Behaviour, Health Belief Model, and Life Course Perspective were 
initially used to better understand the decision-making process.
1.2 Literature Review
To gain an understanding of what has been studied to date pertaining to 
decision-making and the seasonal flu vaccine in older adults, current literature 
was reviewed by searching through journal databases such as PubMed, Scopus,
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Web of Science, The CINAHL Database, ProQuest Nursing Journals, 
PsychINFO, and Physical Education Index. Using keywords such as ‘vaccine’, 
‘influenza’, ‘elderly’, ‘senior’, ‘attitude’ and ‘knowledge’, approximately 7,000 
articles were returned. The criteria for being considered a “relevant” article 
included: (1) research on older persons (65+ years); (2) the topic of seasonal 
influenza or pneumococcal vaccines (the vaccine to prevent pneumonia); (3) the 
decision-making process regarding public health services; (4) attitudes, 
perceptions and knowledge; (5) written in the last 15 years; and (6) written in the 
English language. After a brief scan of the titles, articles were either kept or 
eliminated based on their relevancy. The abstracts of the remaining 250 articles 
were reviewed and irrelevant articles were removed. In total, 43 journals articles 
were reviewed that directly related to attitudes and dispositions of elders in 
regards to either seasonal influenza vaccine or the pneumococcal vaccine. 
International research on the decision-making process of older adults has been
conducted using many methods; a summary of the most relevant findings for.this
\
study are presented here.
Researchers often categorize participants by demographic variables such 
as age, gender, ethnicity and education. Quantitative analysis often involves the 
examination of the effect of demographic variables on outcomes. Particular 
demographic variables have been shown to either increase or decrease the 
likelihood of vaccine uptake in elderly participants. In a mixed methods study 
conducted in England by Burns, Ring, and Carroll (2005) and an American study 
by Chi and Neuzil (2004), gender was not shown to be a predictor of vaccine
14
uptake. However, quantitative studies by Kamal, Madhaven, and Amonkar 
(2003), and Mangtani, Breeze, Stirling, Handles, Kovats, and Fletcherm (2006) 
reported that more males received the influenza vaccine than females, according 
to a self-reported questionnaire. Using secondary analysis from the Canadian 
Study on Health and Aging, Andrew, McNeil, Merry, and Rockwood (2004) found 
that vaccine uptake was positively correlated with age (for those over the age of 
65 years), upon completing a univariate and multivariate analysis. This can be at
r
least partly explained by an individual’s reduced immunity as one grows older. 
Also, it may be explained by the fact that as individuals grow very old, they are 
less likely to be making their own, independent decisions, for example, as in a 
nursing home. On the contrary, Evans and Watson (2003) found that among 
individuals over the age of 65 years, a positive predictor for vaccine uptake 
included a younger age. There seems to be great inconsistencies in the findings 
regarding how age and gender influence vaccine obtainment in older adults.
Using narrative interviews and postal questionnaires, some researchers
\
found that living with other people, regardless if they are friends or family, and 
being married are major indicators for being vaccinated (Andrew et al., 2004; 
Burns et al., 2005; Evans, Prout, Prior, Tapper-Jones, & Butler, 2007; Santibanez 
et al.-, 2002). Similarly, Mangtani et al. (2006) found that community dwelling 
individuals, not living with others was a positive predictor for not receiving the 
vaccine. In two studies with community dwelling elders, the amount of knowledge 
an individual possessed regarding influenza and how the vaccine works was 
found to be a good indicator of vaccination receipt (Santibanez et al., 2002;
15
Sengupta, Corbie-Smith, Thrasher, & Strauss, 2004). Ridda, MacIntyre, and 
Lindley (2009) used open-ended interviews with hospitalized patients in Australia 
and found that non-receivers were more likely to be less knowledgeable and 
report inaccurate symptoms of influenza and false side effects of the vaccine. 
Andrew et al. (2004) found that the greater number of years of formal education 
that participants had achieved showed a positive correlation with vaccine uptake. 
A large-scale research study with 3,544 individuals, specifically targeting racial 
disparities in the United States of America, found that African Americans were 
two to three times less likely to receive the influenza vaccine compared to 
Caucasians (Lindley, Wortley, Winston, & Bardenheier, 2006). However, in 
another American study of 324 participants, there was no significant difference in 
vaccine uptake when results were stratified by race (Chi & Neuzil, 2004); thus 
further highlighting the variability in current literature. Postal and telephone 
questionnaires revealed that access issues such as a lack of transportation was 
not shown to be a significant barrier for older adults seeking the vaccine 
(Mangtani et al., 2006; Santibanez et al., 2002).
Numerous studies from America, Canada, Denmark and Britain have 
consistently demonstrated that older adults, both receivers and non-receivers, do 
not think that they are at risk for contracting seasonal influenza despite the 
research that suggests immune systems decline in function with age (Andrew et 
al., 2004; Evans et al., 2007; Mangtani et al., 2006; Nexoe, 1998; Santibanez et 
al., 2002). Using narrative interviews, Evans et al. (2007) found that participants 
believed that health had nothing to do with age. In another qualitative study using
16
interviews, Harris, Ghin, Fiscella, and Humiston (2006) found that only non­
receivers believed that vaccines were irrelevant to health. However, Andrew et 
al. (2004), and Evans and Watson (2003) found that their participants did believe 
that age had an effect on health. The findings from these studies reflect the 
seemingly contradictory trends among community-dwelling elders.
Some of the barriers that non-receivers reported include beliefs of harmful 
side-effects (Chi & Neuzil, 2004; Cornford & Morgan, 1999; Evans & Watson,
2003) , inefficacy (Burns et al., 2005; Evans et al., 2007), and the notion that the 
vaccine itself would give you the disease (Harris et al., 2006; Mangtani et al., 
2006; Ridda et al., 2009; Sengupta et al., 2004). Those who took the vaccine 
thought differently of the side-effects and believed they were manageable 
(Cornford & Morgan, 1999; Evans & Watson, 2003; Telford & Rogers, 2003). In a 
literature review on this topic, Ward and Draper (2008) reported that a : 
recommendation from a health care worker or general practitioner (GP) was 
positively correlated with vaccine uptake. Family and media prompts were only 
moderately associated with vaccine uptake (Evans et al., 2007; Sengupta et al.,
2004) . Comparatively, family and media prompts were not at all associated with 
vaccine uptake in the study by Evans and Watson (2003).
Interestingly, studies from England (Burns et al., 2005; Telford & Rogers,, 
2003), America (Harris et al., 2006) and Australia (Ridda et al., 2009) revealed 
that government and medical mistrust was an important factor in seasonal 
influenza decision-making for both receivers and non-receivers; “Bad 
experiences” in both a historical and social context also contributed to why some
17
individuals chose not to receive the vaccine, although these topics were not 
elaborated on (Harris et al., 2006). As many of the studies demonstrate, several 
gaps and inconsistencies are obvious. This may be due to methodological issues 
including the sampling of participants with varying demographics variables such 
as age, ethnicity or living status (community-dwelling versus institutionalized). 
Additionally, contemporary research fails to allow group discussion and 
exchange of personal opinions, and experiences about decision-making for the 
receipt of the seasonal influenza vaccine, within a Canadian context. From a 
population-based perspective, improving vaccine uptake rates is critical in limiting 
the number of influenza outbreaks and cases per year. On an individual level, 
prior history, allergies, pain tolerance and other personal aspects will guide those 
in choosing whether or not they should receive the vaccine.
The purpose of this study was to understand the self-perceived influences 
on community-dwelling older adults in deciding to take or not take the seasonal 
influenza vaccine.
\
The research objectives of this study were to:
• Explore which facilitators influence decision-making on influenza 
vaccination in older adults;
• Explore which barriers influence decision-making on influenza vaccination 
in older adults;
• Attempt to understand how beliefs impact the decision-making in older 
adults related to the receipt of the influenza vaccine; and
• Attempt to understand in what way knowledge about influenza and the
18




A qualitative cross-sectional design was used with focus groups as the 
method of data collection. Qualitative methodology allowed individuals to freely 
express the array of influences that impacted their preventative health decisions. 
This study was informed by van Manen’s theoretical approach for conducting 
phenomenological research. The author's philosophical viewpoint is set within a 
post-positivist paradigm whereby knowledge is based on human conjecture. 
Phenomenology was chosen to capture the essential meaning of the decision­
making experience as it was lived. Phenomenology is not only a method, but also 
a philosophy. Dowling (2007) described how the philosophical viewpoints and 
methods used in phenomenology have changed over time from a traditional 
European approach originally discussed by Edmund Husserl, to the post-modern, 
American approach described by Max van Manen. Van Manen’s approach is 
similar to Husserl’s in that the writing of a phenomenon should be descriptive, but 
different because experiences should also be interpreted (van Manen, 1990).
Van Manen uses the terms ‘experience’ and ‘phenomena’ interchangeably.
Traditionally, focus groups did not fit within the tenets of 
phenomenological research; however, in 1982 Spiegelberg described how group 
phenomenology, a process by which groups of 6-16 people interviewed together 
can be used in post-modern research. This process was incorporated in the 
current study. Ethical approval for this project was obtained from The University 
of Western Ontario Health Sciences Research Ethics Board (Appendix A).
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2.1 Setting
Six focus groups were held at five residences in London, Ontario for the 
convenience of the participants. These residences included Maple Village for 
Seniors, 600 Talbot Street, Granite House, Masonville Manor and Windermere 
on the Mount. Directors of Care, Activity Managers or Building Managers 
facilitated access to study participants. Maple Village for Seniors and Granite 
House were home to residents requiring moderate levels of support. The 
condominium building 600 Talbot Street was home to individuals of all ages, and 
did not provide additional support to seniors living there. Masonville Manor and 
Windermere on the Mount were home to residents requiring low levels of 
support. Support services such as housekeeping and laundry services, health 
assessments, social programs and in-house dining were offered at all sites 
except for 600 Talbot Street. These four residences also had paid staff working 
on-site (e.g., Registered Nurses) and the older adults were considered 
community-dwelling but living with assistance, rather than living entirely 
independently. The four assisted living facilities ranged in price from $1,400 to 
$2,250 per month for basic accommodations which included access to some 
special amenities such as theatre rooms, exercise rooms, fireside parlours or 
swimming pools.
2.2 Participant Recruitment ;
Participants were recruited using two methods. First, posters were placed 
in common places such as hallways, activity rooms and laundry rooms at the 
aforementioned residences. Interested individuals were instructed to contact the
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researcher by telephone. A participant package was given to participants the day 
of the focus group and included a participant contact sheet with the letter of 
information (Appendix B), a consent form (Appendix C), and a brief demographic 
questionnaire (Appendix D). The second method of recruitment involved planning 
meetings with the Director of Care, Activity Manager or Building Manager at the 
recruitment sites. These authorities acted as gatekeepers who informed older 
adults about the study. Again, participant packages were provided to those who 
expressed interest and came to the focus group. Participants who met the study 
inclusion criteria of living in the community without extensive assistance (i.e., 
requiring 24-hour care and supervision such as that offered at a nursing home), 
being over 65 years of age, having normal cognitive function and "fluency in 
English, were invited to participate in focus.group discussion. :
2.3 Data Collection
Data were collected between August and October 2010, the first year after 
a large H1N1 influenza outbreak (December 2009) in Canada. Many of the 
participants who received the seasonal influenza vaccine in this study had also 
received the H1N1 vaccine in 2009, as indicated by self-report. It took additional 
effort to successfully keep data collection sessions focused on the seasonal 
influenza vaccine and not other vaccines such as the H1N1 vaccine, the polio 
vaccine, or the measles, mumps and rubella vaccine. Participants were reminded 
continuously that the topic was on seasonal influenza, not on any other illness.
Literature suggests that while surveys and questionnaires can provide a 
basic understanding of individual attitudes, qualitative techniques such as
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interviewing or focus group discussion can allow the researcher to obtain rich 
contextual data (Flin, Burns, Mearns, Yule, & Robertson, 2006). Individuals who 
had either received or not received the influenza vaccine were mixed together in 
each focus group session, with the exception of focus group six which did not 
have any non-receivers. Focus groups lasted approximately 60 minutes and 
were digitally audio-recorded using a Sony mp3 1C digital audio recording device. 
The researcher prepared the room for participants, provided and set up 
refreshments, and moderated the discussion by adhering to the protocol. At the 
start of each session, the researcher welcomed the group and participants 
introduced themselves. A consent form (Appendix C) and demographic 
questionnaire (Appendix D) was completed by each participant independently. 
The demographic questionnaire reported on age, gender, marital status, income, 
living situation, and current status of influenza vaccination receipt. A brief 
overview of the topic was provided and participants were reminded to repeat their 
name before responding to a question or statement. The focus group protocol is 
provided in Appendix E; the creation of the focus group questions was guided by 
literature on the topic. In accordance with van Manen’s phenomenological 
approach, participants were encouraged to focus on describing the experience of 
decision-making from the inside: the feelings associated with a specific event. 
Participants were also reminded to refrain from sharing any personal information 
learnt through the discussion. With ongoing data analysis, data saturation was 
reached after the sixth focus group. When no new themes emerged, focus 
groups were discontinued.
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Two different assistants were available during focus groups; only one 
assistant was present at a time to help participants complete the demographic 
questionnaires. The assistants also took part in a method of member-checking 
whereby confirmation of common topics was done immediately following the 
completion of the focus group. The assistants made notes during the discussion 
and at the end summarized the common topics on the flipchart visible to all 
participants. The researcher concluded each focus group session by reviewing 
the summary of topics discussed by the participants and asking for further 
feedback. ‘
2.4 Data Analysis
Focus group sessions were transcribed verbatim by the researcher and 
organized using NVivo 8 software. The researcher and two senior researchers, in 
advisory roles, reviewed one transcript and independently created lists of codes 
describing experiences and personal meanings of the study participants. A draft 
of the coding scheme was then used by the researcher and one of the advisors 
to code an additional focus group transcript. The coding schemes were 
expanded and revised in both coding sessions until a consensus was reached. 
The researcher then independently coded the remaining focus group transcripts. 
The fully coded dataset was analyzed using inductive content analysis. Inductive 
content analysis is a process by which raw data is organized into themes based 
on valid inference and interpretation (Auster, 1956). Van Manen (1990, p. 79) 
stated that “phenomenological themes may be understood as the structures of 
experience,” and described three approaches for researchers to uncover themes:
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a) seek globally for the text’s overall meaning, then b) seek for meaning in 
phrases or sentences that are captivating, and finally c) examine the text 
sentence by sentence. All three approaches were used in the current study while 
“keeping the question [of the meaning of phenomenon] open” (van Manen, 1990, 
p. 98); that is, the meaning of the experience of deciding whether to take or not 
take the seasonal influenza vaccine.
A number of strategies were used to ensure rigour throughout this study. 
The researcher used the 'Gold Standard’ of parallel criteria for ensuring good, 
trustworthy qualitative work (Lincoln & Guba, 1985). The ‘Gold Standard’ is 
considered parallel in nature to criteria used to assess the quality of quantitative 
research. The four criteria include credibility, dependability, confirmability, and 
transferability.
By ensuring credibility, the research findings should represent an 
acceptable interpretation of the data, from the perspective of the participants.
This can be achieved by member-checking and peer debriefing. To maintain
\
credibility in this study, member checking was used to ensure that data obtained 
during focus groups was accurate and described the topic being studied. After 
each focus group session, the researcher and the assistant held debriefing : 
sessions. During debriefing sessions the researcher and one of the assistants 
discussed the following questions:
1. What were the main themes or issues that struck you in this focus group?
2. What were you unable to get from this focus group?
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3; Was there anything else that struck you as interesting or important in this 
focus group?
4. What new questions were raised here to pursue in future focus groups? 
The discussion on the previous questions helped the researcher ensure that 
participants were being asked to specifically discuss their own personal decision­
making process.
Dependability relates to the quality of data collection and how well a study 
could be repeated. In this study a focus group protocol was developed and 
followed closely to ensure dependability of data collection and analysis. Also, 
three individuals including the researcher and two experienced qualitative 
researchers participated in the coding process to ensure accuracy and quality. 
Finally, the details of the study procedure, including rich descriptions of 
participants, were recorded in length and are available to those who are 
interested in executing a similar study method.
Confirmability depicts how well findings are supported by data and not by 
researcher bias. To maintain acceptable confirmability, Lincoln and Guba (1995) 
suggest that the researcher engage in reflexive techniques during data collection 
and to have experts review research findings. Reflexivity is a process by which a 
qualitative researcher consciously engages in self-critique to ensure that his or 
her own thoughts and experiences did not influence aspects of a study (Koch 
and Harrington, 1998). The research assistant helped ensure that all of the 
discussion topics accurately captured the participants’ perspective. The 
researcher was continually de-briefed by a supervisor to assure that the topics
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generated emerged from data and not from personal bias. The researcher kept 
detailed reflective notes throughout each stage of the research process. 
Additionally, the two advisors independently analyzed transcripts, and then 
compared code drafts with the researcher to come to an agreement on the study 
findings. During the coding process the researcher returned to notes kept on that 
particular focus group session. This was done in an attempt to reduce memory 
bias and aid in reminding the researcher the details of that particular focus group. 
In addition, weekly meetings with the thesis supervisor were useful for discussing 
and reviewing research findings.
Finally, transferability relates to how well other individuals are able to 
transfer a study’s findings to another context. In this study, the researcher did not 
attempt to make broad generalizations regarding the transferability of the 
research findings. Instead, rich, thick descriptions of the setting and participants 
were provided to allow others the opportunity to decide if these findings are able 
to transfer to other settings and participants. The future directions of the study’s 




This chapter presents findings from the study and consists of two sections. 
The first section describes the individuals that participated in the study and their 
associated demographic information. The second section outlines and describes 
the themes and codes that emerged from data analysis.
3.0 Participants
Eleven men and 26 women (n=37) took part in six focus groups conducted 
at five residences in London, Ontario. The average age of participants was 82 
years (SD = 6.6, Range 67-91). Participants’ personal attributes from the 
demographic questionnaire (Appendix D) are listed in Table 3-1, suggesting that 
overall the study group was relatively homogenous particularly in terms of age 
and education. The average number of years of formal education was 14 years 
(SD = 2.6), which is on average two years of post-secondary training. Regarding 
vaccine receipt, six participants were identified as those not receiving the vaccine 
(further referred to as non-receivers), and 31 participants as those receiving the 
vaccine (further referred to as receivers). Missing data from the demographic 
questionnaire included 16 participants who did not disclose their primary source 
of income and two individuals who did not disclose their age. All recruited 
participants remained in the study until its completion.
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Table 3-1





























3 AB 0 8 81 (8.0) 15(2.4) 3.0(18) Pension 7 - 1
4 RH 2 5 82 (7.0) 13(2.2) 3.0(10) Pension 6 1 _ .
5 RH 1 4 86 (6.0) : 14(2.2) .■ 3.0(13) Pension 4 . , 1
6 RH 4 3 84 (4.4) 15(2.0) 2.9 (3.0) Pension 7 0
Mean 2 4 82(6.6) 14 (2.6) 2.5 (2.0) Pension 5.2 1.0
Note: R H - Retirement Home, AB = Apartment Building, M = Males, F =
Females, SD = Standard Deviation.
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Among receivers there were two sub-groups: active receivers and passive 
receivers. Active receivers represented the older adults who had taken the 
influenza vaccine regularly since it became available. Active receivers would 
generally seek out the vaccine by asking retirement home staff or their general 
practitioner when the vaccine would be available and where the clinics would be 
administered. Passive receivers represented the older adults who had taken the 
influenza vaccine when it was convenient but they did not actively seek it out. 
Passive receivers generally did not think about why they were taking the vaccine, 
they just simply took it. All thirty-one receivers indicated that they planned on 
continuing to receive the influenza vaccine in the future.
Among non-receivers there were also two sub-groups: active avoiders and 
passive avoiders. Active avoiders had never received the influenza vaccine. This 
was for a very specific reason, most frequently because of a past negative 
experience by a family member or friend. Passive avoiders, however, did not
take the influenza vaccine because it was not convenient, had no desire, did not
\
feel vulnerable, or did not have a particular reason at all. Interestingly, passive 
avoiders expressed that they would have taken the influenza vaccine if they 
became really sick, were strongly advised or simply were forced to do so.
3.1 Qualitative Findings
Participants provided rich information about their experiences and 
described factors that influenced their decision-making process on the seasonal 
influenza vaccine. Content analysis produced 15 codes from which five 
overarching themes emerged (Table 3-2). The five themes include: Moderators,
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Beliefs, Prevention, Accessibility, and Knowledge. While the researcher 
attempted to categorize codes according to the most appropriate theme, it is 
possible that some codes could be placed in multiple themes. For example, the 
code fear of adverse events could be placed under theme Moderators or theme 
Beliefs. The researcher placed the codes in their current location as this 
framework worked well with the Health Belief Model. The following section will 
describe each theme with its respective codes and present quotes from focus 




Themes and respective codes which emerged from focus group transcripts
Moderators Beliefs Prevention Accessibility Knowledge













Events Availability , ? • •
;
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3.1.1 Theme One: Moderators
The three codes encompassed by the theme Moderators were: genera/ 
practitioners, intimate relationships, and fear of adverse events. This theme was 
used to describe active influences on older adults. Active influences were those 
which acted directly on an individual.
General Practitioners
Overwhelming response from receivers indicated that general practitioners 
had the strongest influence on their decision to receive the vaccine. Receivers 
made comments such as, “if the doctor recommends it, I just take his or her word 
for it,” or “the doctor recommended it and I figure they know more about it than I 
do,” and “I just trust my doctor, when he said I needed it, I took it.” Receivers 
expressed extensive trust in the health care system and the willingness to put the 
ownership of their health in their physicians’ hands. A participant said “the doctor 
recommended [vaccine] and we have full confidence in our doctor’s 
recommendation to follow his advice.” '
All but one non-receiver indicated that at some point in their lifetime a 
physician recommended an influenza vaccination. However, their general 
practitioners did not pressure them into getting the influenza vaccine. This was 
important to the non-receiver participants as they felt in control of their own 
decision and were not forced to take the vaccine. Half of the non-receivers 
mentioned that if, in the future, a doctor stressed the importance of the influenza 
vaccine, then they would probably reconsider their decision and take the vaccine 
to appease their physician.' :
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None of the study’s participants could remember their family doctor 
explaining what the vaccine contains and how it worked in the body. Although 
receivers did indicate that “the doctor marks [vaccines] off and keeps track of it 
[...] they always ask you when are you going to be here for the flu shot.” Another 
participant mentioned that “[the doctor] puts a note on the door [... that] it’s time.” 
Finally, a participant reported that “I’ve been getting a phone call from my 
doctor’s office saying did you get a flu shot and please call us.” Participants 
frequently discussed the proactive nature of their physicians and indicated that 
they often promoted the vaccine. For receivers, this was a strong facilitator 
during decision-making.
Intim ate Relationships
Intimate relationships functioned as both a facilitator and barrier for receipt 
of influenza vaccine, where spousal influence was stronger than influences by 
children or friends. One older lady said that “[...] my husband always got the flu 
shot so I figured I better get it too.” An older man said, “I think I’ll do it myself 
because well, if I don’t, I’ll get hell from her [my wife].” Another older man said, 
“whenever I was home my wife always says ‘time for the flu shot.’ I said ‘do we 
have to’? And she said ‘yes we have to’.”
On the other hand, the vast majority of the older adults’ children reportedly 
did not advise their older parents to get the influenza vaccine. Only one 
participant said, “I’ve had two kids who are in the medical field and they’ve 
always reminded us.” The older adults said that they were the ones who advised 
their adult children (if they had any) to take the vaccine, although it was stressed
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that their children made their own decisions regardless of what the parents had 
advised. ' ,
When asked if participants reminded their friends to get the influenza 
vaccine, one individual said “nope, none of my friends ever sit and talk about it.” 
However, one participant said that, “if we’re all sitting around here and the person 
next to me is coughing their head off, you know, I think right then [...] oh geez 
maybe I’m going to get what she has, the flu I’m going to get,” and then would be 
reminded to get the influenza vaccine. Similarly, one participant became a 
receiver only after she arrived at the retirement home because she thought she 
was more vulnerable to transmission as a result of living in close quarters among 
others. Although the older adults may not have directly spoken to one another 
about the influenza vaccine or the influenza illness, other older adults’ presence 
in the building facilitated some participants’ decision to take the vaccine.
The influence of friends acted as a barrier to receiving the vaccine among
non-receivers. One lady said, “my friends got so sick, I didn’t want any part of the
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vaccine.” And another older man said, “the guy [friend] who took it said he was 
stuck taking [the vaccine] every year, now this year he’s taking [the vaccine], he 
said better stay away. That was his advice to me.” Apparently this friend had 
informed the participant that if you take the vaccine once, you must continue 
taking it ever year. Although this information is incorrect, the participant did not 
want to take the vaccine every year because he thought it would be a hassle.
Fear o f Adverse Events
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Adverse events were described by participants as side-effects or 
symptoms that should not normally occur after receiving a vaccine. Nearly all of 
the study’s participants had heard of others (e.g., friends, family, neighbours, 
etc.) who had experienced adverse events which were attributed to the influenza 
vaccine. These experiences ranged from mild (e.g., sore arm) to severe (e.g., 
infection, paralysis). However, only four receivers reported that they had 
personally experienced an adverse event post-receipt, which did not prevent 
them from receiving the influenza vaccine again in consecutive years.
When asked if participants feared the possibility of experiencing a post­
receipt reaction, non-receivers were considerably more fearful when compared to 
receivers. Only one receiver expressed her fear of experiencing a~fatal adverse 
event with a subsequent loss of control over the cause of her death. She said:
I think that’s a real problem in not knowing for sure whether you’re going 
to be dying of natural causes or gee if I get this flu shot, I may shuffle off 
with it [...] you may not be ready to plan your funeral yet.
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Half of the non-receivers indicated that adverse events were the primary reason 
that they did not take the influenza vaccine. One fearful non-receiver said:
That’s the reason I don’t take it. My adult children have had reactions both 
times, you know both of them each time, [daughters] have had the flu 
shot. I don’t want to get sick from someone giving me a needle.
A second non-receiver indicated that he did not take the vaccine because he 
believed he would have to take it every single year afterward. A third non­
receiver said, “I have had friends who have taken it and been very, very sick, so
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that turned me right off.” One participant agreed and responded, “after they got 
the shot, the ingredients that were in the shot made them sick, that’s what I 
think.” Another participant agreed and shared this story:
I had a neighbour who had a terrible side-effect several years ago. She 
was 90ish and she was paralyzed for about 24 hours and they were really 
concerned. She came out of it, she was fine but her doctors told her never 
again to take it, the vaccine.
Receivers indicated that the possibility of an adverse event was a risk that they 
were willing to take when they chose to have the vaccine. One receiver said, “it 
didn’t bother me, now if it bothered me I wouldn’t get it.” The receivers indicated 
that adverse events were not that serious. When asked what kind of mild 
symptoms they had experienced, one participant said, “a sore arm, a little 
inflamed that’s all.” The fear of adverse events was a barrier for non-receivers 
only.-,' ,
3.1.2 Theme Two: Beliefs
\
The three codes encompassed by the theme beliefs were: choice, risk, 
and vaccine efficacy. This theme described how participants’ beliefs about 
seasonal influenza and the associated vaccine related to their decision to receive 
or not receive.
Choice
Participants provided insight into their perceptions of the freedom they had 
in choosing to take or not take the influenza vaccine. About half of the individuals
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in this stùdy verbally expressed their belief that they had the freedom to choose. 
A non-receiver said, “[doctors will] suggest what you can and can’t do but it’s 
entirely up to the person themselves whether they get it.” Other participants said, 
“yeah it’s a personal decision,” “it’s your own decision whether you take it,” and 
“It was entirely my own thought, I think.”
Four individuals reported that their original decision may not have been 
their choice, or that their decision was strongly influenced. On participant said, “I 
started taking them when the government started asking you to take flu shots." 
Subsequent influenza vaccinations were the result of continued prompting from a 
general practitioner, or a spouse. One lady said, “well, as a rule, when my 
husband was there [at the physician’s office] you had to take [vaccine]... it was 
not a question if you wanted it, if he was having it, you were having it.” Other 
participants did not know or did not express if the original decision to receive the 
influenza vaccine was made for them. Participants did not report that residing in 
an assisted living facility removed any control over their choice to receive or not 
receive the influenza vaccine.
Interestingly, three receivers indicated that they were health professionals 
before they retired. One participant said that being employed as a nurse and 
being pressured to take the vaccine during employment had a strong influence 
on her decision to continue to receive the influenza vaccine in later years; the 
other two receivers had similar narratives.
Risk
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Risk was a code used to describe how vulnerable participants believed 
they were in contracting seasonal influenza. All of the study participants agreed 
that older adults are more at risk for contracting influenza. One gentleman said, 
“because of our age, our immune systems are lower and if you catch a cold, 
before you know it you’re in the hospital, you got pneumonia.” Other participants 
agreed and reported that, “older seniors with weakened conditions,” and “the 
elderly” are more at risk. All participants indicated that pregnant women, 
teachers, healthcare workers, children and individuals with immune- 
compromised health were also more subject to contracting influenza.
However, participants believed that an individual’s risk of contracting 
influenza was inherent in nature and that every person is unique,"therefore, they 
might be more or less vulnerable than others. For example, seven receivers 
believed that they were at a higher risk of contracting influenza and this belief 
facilitated them in taking the vaccine. This high risk was due to their tendency to 
catch other illnesses such as pneumonia and bronchitis. This perceived 
vulnerability heavily influenced their decision to receive the vaccine. One receiver 
said, “I’m subject to colds. I’ve had rheumatic fever [...] so consequently my 
[immune] system is quite low.” Another participant said, “I just felt it was the 
proper thing to do because I was prone to pneumonia too.” The other receivers 
indicated that even though they were not prone to getting sick or inherently 
vulnerable, they still received the influenza vaccine as a preventative measure to 
avoid getting ill. One participant exclaimed: “I’ve been sick with the flu at least 
once and I don’t want it to happen again, I take the flu shots.
J
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Two individuals were concerned about their risk not because they were 
vulnerable but for other reasons. First, a gentleman indicated that he took the 
influenza vaccine as an adult because he did not want to risk missing work as he 
was the owner of a local business:
Seems to me that when I first got the flu shot I was running my own- 
business and I was terrified of not being there to take care of it because of 
illness so I wanted to take every precaution possible.
Second, an elderly lady, which only started taking the influenza vaccine when 
she came to the retirement home, said that she was “more at risk in a way 
because we live in a community, rather than being a couple in a home.”
Interestingly, all six non-receivers indicated that they were not in need of 
the vaccine because they were not vulnerable and were not at risk of contracting 
the disease. One non-receiver said, “so far I’m okay, I never get any flu, I never 
get [influenza].” A third of the non-receivers reported they would only get the 
influenza vaccine after they had actually gotten sick and with a doctor’s
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persistent recommendation. This perceived resilience of an older adult was a 
powerful influence for non-receivers to continue not taking the vaccination.
Vaccine Efficacy
Participants were asked if they believed the vaccine was effective in 
preventing influenza. All 37 participants indicated that they did not know for sure 
that the vaccine was effective but that they “believ[ed] in it" despite that “some 
people get the flu regardless whether they have had [vaccine] or not.” All 31 
receivers agreed that because they had been taking the vaccine for decades,
and had not gotten sick, their experience was all the proof that they needed. One 
participant said, “I do believe in it, the flu shot, my wife does and she has never 
had the flu." When asked if the vaccine works as well as authorities report, one 
man said, “I have no reason to think it doesn’t.” Another participant agreed and 
said; “Well I’ll tell you it’s advertised so much how good it is so how can you ever 
pick it apart and say it’s not good." The belief in vaccine efficacy was extremely 
persuasive and facilitated receivers in the decision-making process. One 
individual attributed this belief in vaccine efficacy to her belief and trust in health 
science. She said, “I have great respect for science and I think that a lot of work 
as been done for [vaccine], and we are the ones that benefit from that work.” 
Other participants said things such as, “I think it’s a good deterrent, I really feel 
it’s a good thing to do,” “I think it works,” “I think it protects you," and “I think it 
works, I think it works exetremely well. I think it does, it must.” This belief and j 
trust in health science is similar to participants’ belief and trust in their general 
practitioners’ capabilities, and more largely, the healthcare system.
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3.1.3 Theme Three: Prevention
The two codes encompassed by the theme prevention were: health 
behaviours, and protection. This theme captured discussion around the role of 
the vaccine as part of a larger health plan, both individually and systemically.
Health Behaviours
Participants were asked to describe how they attempted to remain healthy 
in later life. Potential similarities and differences in health behaviours existed
4 0
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between receivers and non-receivers. All of the receivers said that taking the 
influenza vaccine was just a part of the way they tried to stay healthy. One 
participant said, “I think it’s just something you do as part of your health, just like 
you try to eat properly,” and another said, “for me it’s a matter of health practice 
to do it. As [much] as it is going every six months and getting my teeth checked.” 
Receievers reported that they used other strategies to prevent contracting 
influenza such as washing their hands, avoiding sick people, staying in their 
room when they were sick, taking vitamins, exercising, resting, having tissues on 
hand, and eating and drinking well. One gentleman said, “I think if you have the 
right diet and stuff, take some vitamins, that you can fight the flu or cold much 
better.” Wanting to be healthy facilitated those in deciding to receive the vaccine.
Only a third of non-receivers specifically reported using preventative 
health behaviours such as those listed above. One non-receiver said, “I think you 
need lots of sleep, lots of sleep [...] and use your elbow [for sneezing].” It 
appears that this non-receiver relies on her body’s natural defense system to 
fight off illnesses. Another lady said that when she felt ill in any way, she would 
take castor oil.
Protection
For some of the study’s participants, their primary reason for receiving the 
vaccine was for the protection of others. Many receivers reported that they took 
the influenza vaccine because they wanted to protect their spouse, or “[those] 
with a compromised illness or who is elderly.” Two receivers had spouses who 
were ill with co-morbid conditions and they felt they could better protect their
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spouse’s health by getting vaccinated. One lady said, “my husband wasn’t well 
and he would have a fit, if I didn’t get the flu shot then I might give him the flu.” 
Another lady reported, :
When I started [receiving], he [doctor] recommended me taking it way 
back when because my husband had weak lungs and was prone to having 
pneumonia, and this way if I took [the vaccine] he figured my husband 
would be protected more.
One participant thought that “if nobody took shots of any kind [...] diseases would 
run rampant.” Another participant agreed and said, “I think we should take them 
[vaccine] so that we can hold them [disease] down.” Protecting others from 
contacting influenza was a facilitator for some participants to take the vaccine.
3.1.4 Theme Four: Accessibility
The five codes encompassed by the theme accessibility were: cost, 
location, transportation, wait-time and availability. This theme was used to 
describe the factors affecting the older adults’ decision either prior to vaccination 
or during vaccination.
Cost; ■
Participants reported that they were grateful for Canada’s current 
universal healthcare system as many participants had to pay for medical services 
in the past. Receivers thought that our hassle-free healthcare system was 
convenient because they could just show up, receive the vaccine and not be 
billed at a later date. One older man said:
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The other thing is it’s free. Alright, it’s not really free, we pay for it in our 
taxes, but you don’t go to a doctor and he gives you the injection and 
gives you a bill for 65 bucks. You just go, give him your OHIP card and 
that’s it.
Free influenza vaccinations were also important because receivers believed that 
in the long run it saved the government money for management of influenza 
among the elderly. Non-receivers indicated that free vaccinations did not 
influence them in any way to get the vaccine.
; When asked if they would or could pay for the vaccine if it was not free, 
participants expressed two different opinions. A third of receivers said that 
although they would not object to a small fee such as $10, they would have to 
reconsider their decision if the cost was much more than that. When asked if cost 
played a part in participants’ decision, one participant said, “it certainly does in 
mine,” and another participant said, “for some people, it’s kind of nice that it’s
free.” Elaborating on the topic, participants were asked if it was helpful that the
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vaccine was free. One participant said, “oh yeah, oh definitely.” Another third of 
receivers said that cost was not a factor at all and that they would pay for the 
vaccine regardless of how much the fee was. One individual said that “there 
would be some people who couldn’t afford it.” Another individual said that “it 
depends on what price you put on your health.” For some receivers, cost was a 
facilitator in their decision to receive, whereas for other receivers, cost was not. 




All of the receivers agreed that regardless of where the influenza vaccine 
was offered, it was every person’s responsibility to go out and get it. However, 
they all appreciated the vaccine being offered in convenient locations that 
reduced standing and waiting, or costs associated with traveling. Some of the 
convenient locations that were mentioned included retirement homes, hospitals, 
doctors’ offices, health clinics, schools, malls, and churches. One individual said, 
“I’ve gotten to the point where any travel is just too stressful for me.” Another 
participant said, “the older you get, you don’t want to stand and wait and wait [...] 
it’s nice that it’s coming into these senior homes.” All of the receivers that could 
receive their vaccine at the residence indicated that this was a facilitator in their 
decision. Participants reported, “I do think it’s nicer if you don’t have to [go 
somewhere], I’m not a person who likes to stand and wait, so it’s nicer when they 
come to you,” and “it’s right there [in the retirement home], it’s much easier.” An . 
older man commended his residence:
It’s also very convenient if you live here and you use the doctor here and 
as we’re having clinic here just get dressed and go down and have it. That 
makes it very convenient. You don’t have to go to some hospital 
somewhere or go to some clinic elsewhere.
Active receivers preferred to receive the influenza vaccine at their doctor’s office 
whereas passive receivers did not seem to mind where they received it.
Transportation
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, To get to the location where influenza vaccinations were being 
administered, participants reported taking their personal vehicle, public transit, a 
taxi, a personal driver, family or friends, a retirement home transportation service 
(e.g., shuttle van) or walking. Individuals from focus group (FG) #1, FG #2, FG #4 
and FG #5 did not have transportation issues for two reasons. First, vaccination 
clinics were held on-site at their residence and second, there was a van or bus 
available to transport residents to their doctor’s office. Conversely, individuals 
from FG #3 and FG #6 were responsible for finding their own way to their 
physicians’ office to receive the flu shot. These individuals reported driving, using 
para-transit or public transit to get to their doctor’s office. Despite the availability 
of a variety of transportation modes in the city of London, four seniors from FG 
#6 indicated that they had to travel across town to get to their doctors’ offices. 
When participants were asked what made it easy to get the vaccine, one 
participant said, “having your own car." Others agreed and said, “yes,” and “that’s 
a big factor.” Participants reported that transportation was not an issue in 
receiving because there was a system in place. However, they said that if this 
system wasn’t in place to help them get around the city, then a lack of 
transportation might seriously change their decision to take it or not.
W ait-tim e
Wait-time was considered to be the amount of time an individual had to
wait in line at the vaccine administration location before they received their shot.(
For some participants, the amount of time they had to wait to receive the vaccine 
was a barrier. Four participants reported that at one time they had waited several
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hours at a health clinic and school to receive the influenza vaccine; two of these 
individuals were passive receivers and two individuals were active receivers  ̂The 
one passive receiver indicated that “by the time you get up there to get the 
needle you’re more [or] less just discouraged.” Similarly, an active receiver said “I 
had no trouble at the health unit, by the time [I arrived] the crowds had died 
down, I guess” [sarcasm]. An older man was particularly upset when,he recalled: 
Well generally you wait and wait, my wife and I used to go way out, we . 
lived in [residence] and generally there were a couple hundred people in a 
line up. By the time you got through, by the time you sat, after you had to 
sit for I think 20 minutes or something, well the whole day is wasted.
Three individuals were upset that the flu clinics held at their retirement home 
“were open to outsiders” (i.e., general public) as this increased their, wait-time. 
Some receivers indicated that they had not experienced wait-times because they 
received their influenza vaccine at their physician’s office. One participant said,
“you get there [the clinic] early and you don’t spend the whole day waiting. I think
\
that’s probably important to seniors.”
\ .  ; ■ . . . .  . .
A vailability
The time of year appeared to cue and remind participants that the 
influenza season was coming. A third of receivers said that they make sure to 
get their influenza vaccine by late October or early November to avoid any 
problems that might occur in January or February, for example, bad weather or 
vaccine shortages. Two receivers even marked influenza vaccine clinic dates in 
their calendars when this information became available.
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Two participants were grateful that they lived in Canada and had access 
to the influenza vaccine. A participant said “we’re lucky to be living in this country 
[...] not the United States." At the time of data collection, the United States of 
America did not have universal healthcare and individuals wishing to receive the 
influenza vaccine would have to pay for it out of pocket. An older man said:
When I [was] in Canada I received it but a lot of countries didn’t have it.
My job was around the world so I didn’t have it [often]. In England we had 
it but it was, I don’t know, well a hit or miss. If you happened to be in that 
area you got it. If you weren’t, well you didn’t.
One participant lived in Britain until he was a senior and reported the influenza 
vaccine was unavailable there during his middle to late adulthood.Living in 
Canada and having access to reliable, annual influenza vaccinations was a 
facilitator for some participants.
All but one receiver indicated that they could get the influenza vaccine at 
any time once the flu season began. Another receiver said that she receives her 
vaccine as soon as possible so as to avoid the possibility of her physician 
running out later on in the season. Participants were aware that in previous 
years, some physicians had run out of the vaccine towards the end of the 
influenza season. At times, during all of the focus group sessions, participants 
became confused as to whether vaccine unavailability came from shortages of 
seasonal influenza vaccine or the H1N1 vaccine. One receiver said that her 
physician did not have the refrigeration capacity in the office to hold large 
amounts of the vaccine and therefore he did not administer the vaccine to his
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patients. This individual mentioned that “[doctor] only had a little bar fridge to put 
[vaccine] in.” It was unknown whether this individual meant the doctor was 
unable to hold influenza vaccine or H1N1 vaccine in the bar fridge.
3.1.5 Theme Five: Knowledge
The two codes encompassed by the theme knowledge were: flu 
symptoms, and vaccine attributes. This theme described the knowledge older 
adults had regarding seasonal influenza and the associated vaccine.
Flu Sym ptom s
Participants were asked to describe what they knew about the seasonal 
influenza regarding its symptoms, severity and duration. Although the 
participants could correctly identify some key symptoms of the disease such as 
fever, headache, cough, sore throat, and running nose, many could not tell the 
difference between a cold and influenza, or define influenza-specific symptoms. 
One older lady said, “you’re sick just like a cold or something like that, I’m not 
sure myself, I think it’s more like a heavy cold maybe.” Other individuals also 
incorrectly concluded that the seasonal influenza was characteristic of a heavy 
cold. Three quarters of all the participants said that they had never personally 
experienced influenza. This was a surprising finding given the contagious 
manner of influenza viruses. Both receivers and non-receivers were aware that 
influenza is a serious illness and can be fatal in some circumstances. The 
participants who had experienced influenza described it as “terrible! If you really 
get a good dose of it you’ll be in bed for a week or more, violently ill.” Other
participants said, “with a real flu you ache, I did. You feel your bones are aching 
and you’re sick to your stomach,” “well if you had it, it’s not fun believe me,” and 
“three days of hell.” When asked how long the illness lasted, one individual said 
that influenza “just seemed to have to wear off.” Overall, all participants had ; 
limited knowledge of seasonal influenza. The amount of influenza knowledge a 
participant had was unrelated to their identity as a receiver or non-receiver and in 
this study influenza knowledge was not an element in their decision-making 
process. ; v
Vaccine A ttributes
The study’s participants knew little more about the seasonal influenza 
vaccine than the seasonal influenza illness. When asked to describe what was in 
a flu shot, six individuals correctly reported that the vaccine contained multiple 
virus strains that were most prevalent from the year before. One participant said, 
“the flu shot vaccine is what we had last year. The kind of viruses that were 
available last year so in actual, the vaccine we have this year is virtually a year 
behind, what we’re getting.” Only one of these individuals worked as an allied 
health professional before retirement. Another participant said:
Now let’s get a little bit deeper into [...] what is a flu shot? I understand 
that if you're trying to get down something to kill something, to help some, 
actually what they do is put that disease into your system. Now I don’t 
[know] whether that’s true or not but there are different things you get and 
one disease kills the other, so to speak.
Participants could not agree on whether the viral strains were alive (active)
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or dead (inactive). Only four out of 37 individuals were able to correctly explain 
how the vaccine worked inside their body. One participant thought that “the flu 
shot contains a little bit of the flu strain and you’re injected with it. Your body will 
fight that little strain off and you’ll be prepared if you’re infected with the regular 
flu, you’ll be ready and prepared.” Some participants described incorrect ways a 
that the vaccine worked such as: the vaccine contained synthesized viruses, the 
vaccine was an antibody, and the vaccine was a “mild form” of the flu. These 
individuals justified post-vaccine influenza symptoms as a result of these 
incorrect theories.
Despite that, some participants had vaccine information on adverse 
events, method of delivery, vaccine efficacy or makeup, nearly one quarter of all 
participants had no vaccine knowledge at all. Some participants said, “I really 
don’t know anything about it other than it helps you from the flu,” “I don't 
understand the flu shot, I don’t know how they make it,” and “I have no idea.” 
Overall, all participants had limited knowledge of the seasonal influenza vaccine. 
The quantity and correctness of vaccine knowledge that a participant had 
attained was unrelated to their identity as a receiver or non-receiver and did not 
contribute to their decision-making process.
In summary, the most prominent factors which facilitated individuals 
receiving the vaccine were the recommendation by and trust in the health care 
system, and a belief in vaccine efficacy. The most prominent factors which 
hindered individuals from receiving the vaccine was the fear of adverse events 
and a belief in resilience as an older adult. In the next chapter these findings will
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be discussed in terms of timing in the decision-making process and how these 
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4 DISCUSSION
The discussion section will: present the major influences on older adults in 
deciding to take or not take the seasonal influenza vaccine, compare findings of 
this study to previous work on the subject, and finally, discuss the implications of 
the findings on subsequent theories of decision-making.
4.0 Summary of Findings
The findings of the study show that a multitude of factors contribute to an 
older adult’s decision to either receive or not receive the seasonal influenza 
vaccine. In this study, older adults lived alone or with a partner in an apartment : 
with or without some assistance. Each participant self-identified as either a 
receiver or non-receiver. Receivers indicated that general practitioners had the 
strongest influence on their decision to receive the vaccine and expressed 
extensive trust in the health care system and the willingness to put the ownership 
of their health in their physicians’ hands. Receivers were considerably less fearful 
of experiencing a post-receipt adverse event when compared to non-receivers. 
Three out of six non-receivers indicated that the potential for adverse events was 
the primary reason that they did not take the influenza vaccine. The belief in ; 
positive vaccine efficacy, without knowing the evidence, was also persuasive for 
receivers. While most receivers believed they were at risk for contracting 
influenza because of their age, all of the non-receivers did not think that they 
were at risk for transmission. The non-receivers reported feeling resilient and not 
part of a vulnerable population; however, this could have just been strategy to 
justify their decision. Regardless, this perceived resilience was a powerful
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influence for non-receivers to continue not taking the influenza vaccine. Both 
receivers and non-receivers had a lack of knowledge regarding influenza-specific 
symptoms and the vaccine, which also did not influence their decision: Intimate 
relationships between spouses, or parents and children, were all less influential. 
However, non-receivers reported that hearing about their friends’ adverse 
experiences with the influenza vaccine side-effects played a part in their 
decision-making process.
4.1 Comparison with Existing Literature 
This study did not attempt to find a relationship between gender, age, level 
of co-morbidity, number of years of formal education, and the receipt of the 
seasonal influenza vaccine. Although 70% of all participants were female, this 
gender overrepresentation parallels the Canadian older adult population. In 2010, 
59% of individuals between 80 and 85 years were female (Statistics Canada, 
2009b). Research by Burns et al. (2005), and Chi and Neuzil (2004) did not show 
that gender was a predictor of vaccine uptake. From 1996 to 2007, Statistics 
Canada (2008) reported that men and women had fairly similar vaccine uptake 
rates. Uptake in men had increased from 47% in 1996 to approximately 63% in 
2007. Similarly, uptake in women had increased from 49% in 1996 to 66% in 
2007 (Statistics Canada, 2008). Promoting the influenza vaccine to one gender 
or another most probably does not influence uptake overall.
The most influential decision-making factor for receivers in this study was 
the recommendation by a general practitioner. Many other studies including 
Burns et al. (2005), Chi and Neuzil (2004), Evans and Watson (2003), Nexoe
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(1998), Sengupta et al. (2004), and Ward and Draper (2008) reported similar 
findings. A third of the non-receivers in this study, and the non-receivers in a
study by Ridda et al. (2009) reported that they would only take the vaccine if they
were strongly advised by their physician to do so. This suggests the crucial 
influence of GP prompts in the decision-making process. The patient-physician 
relationship is built on trust, respect and knowledge. The stronger the
on all health aspects including preventative health measures (Goldring, Taylor, 
Kemeny, & Anton, 2002). The participants in this study reported that they were 
not strongly influenced by other health professionals such as registered nurses, 
practical nurses or physiotherapists. Similarly, Evans et al. (2007)~found that 
registered nurses had only a small influence when prompting individuals to take 
the vaccine: The lack of influence may be due to the fact that vaccine uptake 
rates by health professionals are quite poor in Canada (42% in Toronto, Ontario 
institutional settings) and thus they may not want to promote the vaccine 
(Medical Officer of Health, 2009). An explanation for this may be provided by an 
American study that reported that older adults trusted physicians and 
pharmacists more than nurses, friends, family or the internet (Donohue, 
Huskamp, Wilson, & Weissman, 2009).
In this study, both receivers and non-receivers believed the vaccine was 
effective. Evans et al. (2007) found that a belief in vaccine efficacy was closely 
related with those receiving the vaccine. However, Burns et al. (2005) and Evans 
and Watson (2003) found that non-receivers believed that the vaccine was
relationship, the more likely a patient would be willing to take a physician’s advice
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ineffective and was a primary reason for refusal. Although non-receivers in this 
study believed the vaccine was effective, this was not a strong enough motivator 
for them to receive it.
As demonstrated by the current study and validated by literature, familial 
relationships between spouses, children, and other family members, and friends 
influence older adults’ decision to receive the influenza vaccine (Andrew et al., 
2004; Burns et al., 2005; Evans et al., 2007; Santibanez et al., 2002). However, 
spouses had a stronger influence than the older adults’ children, as indicated by 
overall consensus of the groups. This could be the result of closeness of living 
quarters with a spouse or neighbour of similar age, as opposed to grown children 
living away of home. Additionally, the child parent relationship is very different 
from a spousal relationship. Senguputa et al. (2004) found that advice from the 
community both positively and negatively affected one’s decision to receive or 
not receive the vaccine. However, Evans and Watson (2003) found no
connection between the influence of family and friends, and the decision to
\
receive or not. Whether or not family and friends have an influence on an 
individual may depend on the cultural milieu in which that older adult lives. 
According to Briley (2007), individuals from varying cultural backgrounds have : 
different values which may influence their decision-making process and ensuing 
behaviour. The participants in the current study were not asked which cultural 
and ethnic backgrounds they identified with. '
Burns et al. (2005), and Evans and Watson (2003) reported that 
advertising through media outlets such as television, radio, posters etc. had no
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influence on vaccine uptake. The current study’s participants were aware of such 
media prompts but also reported that they had no impact on their decision for 
vaccine uptake. One possible explanation for the inattention to advertisements 
could be de-sensitization as the result of an H1N1 outbreak in Canada. During 
the 2009-2010 influenza season, there was heavy media coverage, from the 
Canadian Public Health Agency, advising individuals to receive both the H1N1 
vaccine and the seasonal influenza vaccine in tandem. Individuals in this study 
discussed their annoyance with the constant influenza coverage. The role of 
media in over-advertising the influenza vaccine and causing annoyance to the 
public, in general, may account for the low vaccine uptake rates.
Although the current study’s non-receivers believed that thè vaccine was 
effective, the fear of adverse events was sufficient to overcome the perceived 
benefits of the vaccine. Three of six non-receivers indicated that they did not 
want to experience post-receipt symptoms. Findings by Chi and Neuzil (2004), 
Cornford and Morgan (1999), Evans et al. (2007), and Evans and Watson (2003) 
support this conclusion as well. Cornford and Morgan (1999), and Telford and 
Rogers (2003) found that receivers interpreted adverse events differently than 
non-receivers. Similarly, one receiver in the current study said that he felt pain at 
the site of injection but that that was normal and it would not stop him from 
having another shot. Non-receivers were also fearful of contracting influenza or 
other diseases from the vaccine itself; this ideology is frequently present in 
related literature (Harris et al., 2006; Mangtani et al., 2006; Ridda et al., 2009; 
Sengupta et al., 2004).
Recipients of the vaccine discussed their belief in whether or not they had 
control over the decision-making process in regards to receiving or not receiving 
the vaccine. Some participants said that they had complete control over the 
decision whereas others said that the decision was probably made for them in 
the beginning. In a 2001 survey conducted in Alberta, Canada, nursing home 
vaccine uptake rates were as high as 95% for institutions having influenza 
vaccine standing orders (Russell, 2001). Individuals living in an Ontario nursing 
home are also heavily persuaded to receive the vaccine as a result of the 
constant influenza awareness that the health care professional staff deliver 
(Extendicare, 2011). Individuals living in low support retirement homes or on their 
own in the community are exposed to fewer direct reminders which may help 
explain why vaccine uptake rates are not meeting the set targets.
All of the participants in this study were aware that adults over 65 years of 
age should be vaccinated annually because of their particular vulnerability.
However, most of the study’s participants believed that they personally were
\
resilient to influenza transmission. Only one quarter of receivers had a strong 
fear of contracting the illness because of their poor immune systems. Although 
Harris, et al. (2006) found that non-receivers believed that vaccines were 
irrelevant to health, the non-receivers in this study did not have such extreme 
beliefs. The non-receivers just simply did not think they were at risk of influenza 
transmission and that their immune systems were in good health. Andrew et al. 
(2004) and Evans and Watson (2003) have shown that belief in resilience of
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older adults plays a critical role in the decision-making process as it is a positive 
predictor for vaccine uptake.
Many participants felt they had their own ways of preventing influenza. 
Similarly, individuals in a qualitative study by Evans et al. (2007) reported that 
they had specific health behaviours that would prevent or reduce their chance of
influenza transmission. Receivers reported using both health behaviours and the
(
vaccine for protection whereas non-receivers thought they could fight off illness 
with their own remedies. Additionally, receivers believed it was important to 
receive the vaccine to protect others from transmission; while non-receivers did 
not engage in this discussion. While it is recommended to individuals of all ages 
to engage in a healthy lifestyle to reduce the risk of chronic disease, health 
behaviours have not been shown to prevent influenza-related illness (Bovier, 
Chamot, Gallacchi, & Loutan, 2001).
Accessibility issues relating to the cost of the vaccine, location of 
administration, transportation and availability were not prevalent in this study. It is 
possible that older adults living in their own private home in the community 
without vaccine clinics onsite may still experience these types of issues. 
Research conducted in Europe and North America has also reported that access 
issues do not impede receiving the vaccine (Mangtani et al., 2006; Santibanez et 
al., 2002). Because there has been emphasis on regular vaccinations by 
governments in North America, influenza vaccine administration is offered in a 
multitude of locations in communities which makes it easier for individuals to 
obtain the vaccine (National Post, 2006). Most issues relating to accessibility
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have been eliminated; the Public Health Agency should be commended for their 
efforts in addressing the matter.
Previous research is confirmed by this study’s finding that there is an 
overall lack of knowledge about seasonal influenza and the influenza vaccine in 
both receivers and non-receivers. Santibanez et al. (2002) performed a study 
whereby older American adults, with an average age of 75 years, were 
interviewed over the phone and were asked to respond to open-ended questions. 
In the Santibanez et al (2002) study, only 44% of participants could accurately 
provide one symptom of influenza. A recent qualitative study by Raftopoulos 
(2007) also reported on the knowledge deficit in community dwelling Greek older 
adults. It is unclear why even educated participants, with 14 years of formal
education on average, and exposed to persistent informative mass media
•  " \ [
advertising, still had relatively little vaccine and influenza knowledge.
4.2 ¡Comparison with Existing Models 
It has been shown that a multitude of factors play a role in the decision­
making process. Some of these factors are highly influential, whereas others are 
not; it also appears that these factors are time dependent and occur in a step­
wise fashion. The researcher used the codes produced by the study’s findings to 
create a model in which the decision-making process for the receipt of the 
influenza vaccine in older adults can be conceptualized (Figure 4-1). This model 
is an original contribution of this study and is not based on prior decision-making 
models used to understand preventative health behaviours.
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Figure 4-1. Model explaining time-dependent factors influencing the decision-making experience in older adults for the 
receipt of the influenza vaccine including: vaccine and influenza knowledge; risk; direct and indirect influences by 




















Identity: Receiver or Non-Receiver Choice or No Choice
i
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The horizontal arrow represents a time-continuum whereby factors 
influencing the decision-making process present themselves over the course of 
an individual’s lifetime. Through this time-continuum an individual develops a 
particular identity: a receiver or non-receiver. An individual may change their 
identity of an active or passive receiver or non-receiver throughout their life 
course. The following factors are aligned above the arrow: vaccine and influenza 
knowledge, risk, physician, media, family, friends, availability, accessibility, and 
choice. Factors which influence an individual early in life are located towards the 
left side of the model and influences that affect one’s decision shortly before 
vaccine administration are located towards the right side of the model.
Here is an example of how the decision-making process may evolve over 
time. A young non-receiver might hear of her friend’s ‘bad experience’ with the 
vaccine that involved an adverse event such as a seizure. Approaching mid-life, 
the non-receiver might perceive herself as extremely healthy and resistant to 
influenza. As an older adult, when the doctor offers the vaccine, the non-receiver 
may choose not to take the vaccine and continually ignore prompts from the 
media, family or friends. When the influenza season arrives and clinics are 
offered, this individual is not concerned about the cost, location, availability or 
wait-time because they have already made up their mind not to receive the 
vaccine. The only time at which her decision can be forcibly changed is when her 
right to refuse vaccination has been eliminated, that is, she no longer has control 
over the decision. This could occur in a nursing home where individuals can 
choose not to be vaccinated, but this decision must be made in writing (Russell,
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2001). This model is beneficial because it adds the fourth dimension, time. With 
the added benefit of understanding how these influences occur over the life- 
course, we can appreciate when influences are expected to occur, and how long 
we can anticipate them to last.
The Health Belief Model focuses on the attitudes and beliefs of an ; 
individual and contains the following six constructs: perceived susceptibility, 
perceived severity, perceived benefits, perceived barriers, cues to action, and 
modifying factors. In the current study the strongest beliefs, as indicated by 
overall consensus of the group, were resilience as an older adult, vaccine 
efficacy, negative adverse events and the trust in general practitioners. These 
four beliefs can be explained by the HBM. From the original six constructs of the 
HBM, perceived susceptibility can explain older adults’ assumptions that they are 
not vulnerable to illness. If an individual does not feel susceptible to transmission, 
they will not feel the need to obtain the vaccine. Participants' belief in vaccine
efficacy can be understood by the construct perceived benefits. Consistent
\
reminders from media, family, friends, and a general practitioner can be 
explained by cues to action, reminders which ‘cue’ an older adult to take the 
vaccine. A fear of adverse events can be explained by the construct perceived 
barriers, in which one is fearful of the physical cost of receiving the vaccine, such 
as experiencing an adverse event. Perceived barriers can also explain issues 
relating to availability, accessibility and choice. Finally, the extent to which an 
older adult is knowledgeable in vaccines and influenza can be explained by 
modifying factors. This construct describes how socio-demographic variables and
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structural variables such as the knowledge of disease may impact decision­
making.
As for the other two.theories that had the potential to explain findings of 
this study, the Theory of Planned Behaviour is missing the element of how 
susceptible an individual believes they are in contracting the illness, which this 
study found to be critical in decision-making. The Life Course Theory places a 
large emphasis on historical and social but not personal events which do shape 
decision-making. Findings in this study suggest that a series of small 
occurrences and interactions, and not major historical, political or social events, 
ultimately influenced and mediated the decision to take or not take influenza 
vaccine. .v ;.■■■■■ ..
4.3 Scope and Limitations
The main goal of this study was to understand what influenced older 
adults living with minor assistance in the community to receive or not receive the 
seasonal influenza vaccine. In terms of qualitative research, this study had a 
large sample size of elderly individuals and a research design that allowed 
individuals to communicate openly without being constricted to select responses 
offered by a questionnaire. The individuals selected for this study were, on 
average, 82 years old. Therefore, the opinions expressed were those from the 
‘old-old’ subgroup of the elderly population. Quite often these opinions are 
overlooked in literature. The old-old subgroup (75-84 years old) has defining 
differences from the young-old (60-75 years old) or oldest old subgroup (85+ 
years old). All participants lived in the community in homes offering no, or low to
64
moderate levels of support. This is Important because it suggests that 
participants had high Independence and less contact with health care providers 
then they would have at a nursing home. The sample size of participants was 
sufficient to achieve data saturation. As a result of the nature of the qualitative 
research approach, a smaller sample size was needed compared to the 
requirements needed in quantitative research. It is crucial in phenomenological 
studies to obtain rich descriptions of experiences from participants. Finally, much 
of the previously published research has originated from Europe or Australia, and 
to the researcher’s knowledge, this is a unique qualitative study on this topic in 
Canada.
The findings of this study should be considered in view of its inherent 
limitations. Twenty-nine participants were recruited from London, Ontario, in 
homes offering assistance. London is a regional centre and health care hub 
located in Southwestern Ontario where everyone has free access to influenza 
vaccinations. Elderly living with any kind of assistance are in contact with 
healthcare staff and this might affect one’s decision to receive the vaccine. In 
Canada, health care professionals are responsible for reminding older adults, on 
a regular basis, to receive the vaccination. In this study, the ratio of receivers to 
non-receivers was approximately five to one, while in London, Ontario, the ratio 
of older adult receivers to non-receivers is approximately three to one. Thus, 
there was an underrepresentation of non-receivers, which might have influenced 
the findings of the study. Some caution is needed as participants self-reported 
their vaccination status, though Mac Donald, Baken, Nelson, and Nichol (1999)
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report the sensitivity for self-report of vaccine receipt to be from 92-100% and 
specificity from 71-98%.
Finally, this study was conducted with methodological rigour and followed 
Lincoln and Guba’s ‘Gold Standard’ of parallel criteria as outlined in the methods 
section 2.4 Data Analysis. Member checking was used to ensure that reporting of 
data was done accurately and represented the thoughts and opinions of the 
study's participants. Given the inherent nature of data collection and analysis in a 
qualitative research study, knowledge is co-constructed with participants and the 
researcher. An attempt was made to remove any bias as result of prior 
knowledge and assumptions from interfering with data conceptualization. 
Reflexive techniques and peer debriefing was essential to ensure this high 
quality data analysis.
4.4 Future Directions and Knowledge Translation
This study has generated findings that will further inform the decision­
making process regarding preventative health behaviours. Future models should 
incorporate the element of time to observe when influences occur and how these 
influences are maintained over the life course. This could be done by conducting 
a longitudinal study involving a large number of participants. Findings suggest 
that further research is needed to explain, in greater depth, the role of family 
physicians, the potentiality of improved education about the vulnerability of the 
elderly, “herd immunity” and side effects related to vaccine intake.
To enhance knowledge translation of study findings, a copy of the study’s 
executive report was provided to Middlesex-London Public Health Unit (Appendix
66
F). Additionally, a summary of findings in lay language and a thank you letter was 
sent to each individual that participated in the study (Appendix F) and each 
gatekeeper that helped to recruit participants. The study findings were also 
presented at: Canadian Geriatric Society 31st Annual Meeting in Vancouver, 
British Columbia; Health and Rehabilitation Sciences Graduate Research Forum 
in London, Ontario; Aging, Rehabilitation and Geriatric Care Symposium in 
London, Ontario; and Canadian Association on Gerontology 39th Annual 
Scientific and Education Meeting in Montreal, Quebec. The manuscript was 
submitted for publication in the peer-reviewed, scientific journal, Canadian 
Journal of Public Health.
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i| |  Decision-making for the Receipt offfl Influenza Vaccination in Community- W esffrn Dwelling Older Adults
Principal Investigator: Aleksandra Zecevic, PhD  
Faculty of Health Sciences, University of Western Ontario
Co-Investigator: Amanda McIntyre, MSc (can.)
Faculty of Health Sciences, University of Western Ontario
LETTER OF INFORMATION
We invite you to take part in this study that will look at why older 
adults choose or do not choose to receive the seasonal influenza 
vaccination. This letter contains information to help you decide 
whether or not to participate in this study. It is important for you to 
understand why this study is being conducted and what it will involve. 
Please take the time to read over this material and feel free to ask 
questions if anything is unclear or if there are words that you do not 
understand.
What is the purpose of this study?
It is estimated between 4000 and 8000 deaths occur annually in 
Canada due to seasonal influenza. Ninety percent of these deaths 
are from the elderly population. Seasonal influenza is a respiratory 
disease which can weaken the immune system and lead to other 
more devastating diseases such as pneumonia, and even death. 
While there is an abundance of information and many vaccination 
programs available in the community, influenza vaccination rates 
remain suboptimal. The purpose of this study is to explore what 
factors influence your decision-making for the influenza vaccine.
Initial here:
8 1
Why have you been contacted?
You have been contacted because you are an independent, 
community dwelling individual and you are 65 years of age of older. .
What is involved if you choose to participate?
This research study will be conducted at a convenient location for all 
participants (ex. library, apartment building common room etc.). We 
would like to invite you to participate in a focus group session with 
five or six other participants that will last approximately 60-90 
minutes. During the focus group we will discuss what types of things 
influenced your decision to receive or not receive the seasonal 
influenza vaccine. We will also ask you to complete a questionnaire 
with demographic information. Focus group discussion will be audio- 
recorded to allow us to analyze the data later on. Audio-recording of 
focus groups is mandatory so if you do not wish to be audio-taped, 
you should not participate in the study.
What happens to the information gathered in the study?
Data collected in the focus group and the questionnaire will be later 
analyzed and eventually published in a scientific paper; you may 
choose to receive a personal copy of the final report. To protect your 
identity, your name will be replaced with a unique code that will be 
used to identify participants in audio-recordings and questionnaires. 
All hard copies of the data will be locked in a cabinet in a secure 
office at The University of Western Ontario, where only the 
investigators will have access. All data will be destroyed after 7 
years. .v- . y ;
What are the risks and discomforts to you if you participate?
There are no known risks associated with participating in this 
j research. However, some people may experience emotional stress 
! when recalling specific memories related to past experiences with 
public health services or vaccinations. You are free to choose what 
you will and will not discuss. You may ask for specific information 




What are the benefits to you if you participate?
There are no known personal benefits associated with participating in 
this study, but you will assist in providing a better understanding of 
why older adults choose or do not choose this particular preventative 
medicine. Your participation is making a contribution to gerontological 
research.
Voluntary Participation
Participation in this research study is voluntary. You may refuse to 
participate or refuse to answer any questions and withdraw from the 
focus group at any time with no effect on your future care. However, 
any information collected up to that point, may still be used in the 
study.
Other Pertinent Information
Please note the consent form attached to this letter. Should you be 
interested in taking part in this studyjDleasesign the consent form 
and contact Amanda McIntyre Please note, not all
participants who complete the consent form will be contacted for the 
study.
If you have any questions or concerns regarding this study, please 
contactthePrim  Dr. Aleksandra Zecevic
■ ■ ■ ■ ■ ■  If you have any questions about your rights as 
a research participant or the conduct of the study you may contact 
The Office of Research Ethics at (519) 661-3036 or by email at 
ethics@uwo.ca. Representatives of The University of Western 
Ontario Health Sciences Research Ethics Board may contact you or 
require access to your study-related records to monitor the conduct of 
the research.
This letter is for you to keep. You will also be given a copy of the 
consent form if you agree to participate.
Initial here:
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il f l  Decision-making ôr Receipt offM  influenza Vaccination in Community- W esSrn Dwelling Older Adults
Principal Investigator: Aleksandra Zecevic, PhD 
Faculty of Health Sciences, University of Western Ontario
Co-Investigator: Amanda McIntyre, MSc (can.)
Faculty of Health Sciences, University of Western Ontario
CONSENT FORM
I have read the Letter of Information, have had the nature of the study 
explained to me, and I agree to participate. All questions have been 
answered to my satisfaction.
Name of the Participant Signature of the Participant
(please print)
Date
Name of person obtaining consent Signature of person obtaining consent
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Focus Group #:
Decision-making for the Receipt of Influenza 
Vaccination in Community-Dwelling Older Adults
DEMOGRAPHIC QUESTIONNAIRE
This questionnaire should take approximately 5 minutes and will include 
information about age, gender, marital status, income, living arrangements, 
chronic illnesses and influenza vaccine receipt. You can skip any question you











W ith w hom  do you live?
□ Living Alone
□ Living with spouse/partner/roommate
□ Living with children
□ Living with other family members
W hat is your m ain source o f income?




□ Do not wish to disclose
Education
□ Grade 8 or less
O Grade 9 to Grade 12





Do you reside in a/an:
□ Urban area (e.g. downtown)
□ Rural area
□ Suburban area (outside city)
□ Unsure
How m any children do you have?
Do you suffer from  any o f the following illnesses?




Did you receive the flu shot this year?
□ Yes
□ No
□ Don’t Know/Can’t Remember
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• Overview of the topic
• Provide guidelines and ground rules for speaking (one at a time, always 
say your name)
• Start recording
Hi! My name is Amanda and I'm working on a study to try and understand why 
people do or do not get flu shots. I would like to talk to you about what influenced 
your decision to receive or not receive the vaccine.
FOCUS GROUP QUESTIONS
1. ) What do you know about seasonal influenza and it severity?
• Who is most at risk?
• What kind of complications can occur?
2. ) What do you know about the seasonal influenza vaccine and how well it
works?
• Works well/Doesn’t work well
• Side-effects are major/Side-effects are minor
3. ) What types of things contributed to your decision to receive or not receive
the influenza vaccination?
4. ) What types of things made it easier to obtain the influenza vaccine?
• Family, friend or other social pressures?
• Media -  radio, television, advertisement etc.
• Physician recommendation?
• On a priority list?
• Positive past experience?
5. ) What types of barriers did you encounter that may have restricted your
ability to receive the vaccine?
• Personal experience involving adverse reactions?
• Negative past experience?
• Not on priority list?
• Past historical events?
• Access issues?
9 0





Thank you for participating in the study conducted at [Place of Residence] 
regarding the decision-making process of older adults as they choose to either 
take or not take the seasonal influenza vaccine. The comments you provided 
during the focus group were extremely useful and I am grateful for your input in 
this project.
The data obtained from multiple focus groups has been reviewed and the major 
findings of the study are included in the attached Executive Summary. Please 
feel free to contact me by email or telephone if you have any questions about the 
attached report. I hope that you find it interesting and informative.
Your participation has allowed the study authors to gain a better understanding of 
the decision-making process in older adults regarding one aspect of preventative 
health behaviour.
Sincerely,
Amanda McIntyre, MSc 
Aleksandra Zecevic, PhD 
Faculty of Health Sciences 
School of Health Studies 
Arthur and Sonia Labatt 
Health Sciences Building, Room 220 
London, ON, N6A 5B9, CANADA
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J u n e  1 ,  2 0 1 1
[Address]
To [Gatekeeper];
Thank you for allowing us to conduct the study at [Place of Residence] regarding 
the decision-making process of older adults as they choose to either take or not 
take the seasonal influenza vaccine. Your assistance in organizing participants 
for focus groups was extremely valuable and we are grateful for all of your 
support in this project.
The data obtained from multiple focus groups has been reviewed and the major 
findings of the study are included in the attached Executive Summary. Please 
feel free to contact me by email or telephone if you have any questions about the 
attached report. I hope that you find it interesting and informative.
By allowing us to recruit participants from [Place of Residence] you have allowed 
the study authors to gain a better understanding of the decision-making process 
in older adults regarding one aspect of preventative health behaviour.
Sincerely,
Amanda McIntyre, MSc 
Aleksandra Zecevic, PhD 
Faculty of Health Sciences 
School of Health Studies 
Arthur and Sonia Labatt 
Health Sciences Building, Room 220 





The 2010-2011 influenza season has come to an end. This year Canada 
experienced lower than normal seasonal influenza vaccination rates in all age 
categories. In a recent study conducted by researchers in the Health and 
Rehabilitation Sciences Graduate Program at The University of Western Ontario, 
we investigated what influences a community dwelling older adult in deciding to 
take or not take the seasonal influenza vaccine.
Information collected from thirty seven participants during six focus groups has 
been reviewed and a summary of major study findings are included in the 
attached Executive Summary. Please feel free to contact me if you have any 
questions about the attached report.
Sincerely,
Amanda McIntyre, MSc 
Aleksandra Zecevic, PhD 
Faculty of Health Sciences 
School of Health Studies 
Arthur and Sonia Labatt :
Health Sciences Building, Room 220 
London, ON, N6A 5B9, CANADA
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Executive Summary
: Decision-making for the Receipt of Influenza Vaccination in 
, Community Dwelling Older Adults
Background and Rationale
Seasonal influenza is more commonly known as the ‘flu’. It is an infection of the lungs 
caused by a virus. Influenza symptoms include fever, headache, cough, sore throat, and 
a runny nose (Butler-Jones, 2008). The disease can spread very fast through the 
population by directly inhaling the virus. Seasonal influenza can be dangerous for 'high 
risk’ individuals including children under the age of two, adults overage 65, and people 
of any age with weakened immune systems (World Health Organization, 2009). A 
Statistics Canada report in 2008 showed that there were between 70,000 and 75,000 
hospitalization admissions for influenza and influenza complications. Seasonal influenza 
is treatable and preventable. The most effective way to prevent getting the illness is to 
take the vaccine; many studies have shown that the vaccine is effective in preventing 
death by up to 80% in older adults (Nichol, Margolis, Wuorenma & Von Sternberg,
1994). In Canada about 35% of older adults do not receive the vaccine (Statistics 
Canada, 2008).
The purpose of this study was to understand what influences an older adult living 
in the community to accept or refuse the seasonal influenza vaccine.
Methods
Eleven men and 26 women took part in six focus group discussions at five 
London, Ontario locations. All participants were older than 65 years of age and were 
fluent in the English language. The average age was 82 years. Six participants had not 
received the vaccine and 31 participants had. Group discussions lasted approximately 
60 minutes and were audio-recorded. Discussions were written word by word, and 
analyzed for content to identify predominating themes.
Major Findings
This study found that many factors contribute to an older adult’s decision to 
receive the seasonal influenza vaccine or not. The belief that the vaccine was effective 
in preventing disease, and the risk of contracting the disease as a result of their age, 
was persuasive for receivers. Receivers indicated that their family doctors had the 
strongest influence on their decision to receive the vaccine while spouses and children 
were less influential. The belief that older adults are resilient was a powerful influence for 
non-receivers to decide not to take the influenza vaccine. Most non-receivers were 
fearful of experiencing undesirable events such as symptoms caused by the vaccine 
itself. Although most of the participants had limited knowledge about influenza symptoms 
and the vaccine, they all expressed extensive trust in the health care system. Finally, 
cost of the vaccine, location of administration, wait-times, transportation, and vaccine 
availability did not play a particular role in the final decision to receive it or not.
Strengths and Limitations
The strengths of this unique qualitative study on this topic in Canada include a 
large sample of independent older adults, and a research design that allowed individuals 
to communicate openly. The findings of this study should be considered in light of some 
limitations. Participants were recruited from London, a regional health centre located in 
Southwestern Ontario where everyone has free access to influenza vaccinations. In this
95
study, the ratio of receivers to non-receivers was approximately five to one whereas the 
ratio of receivers to non-receivers in London, Ontario is approximately three to one, thus, 
there was an overrepresentation of receivers.
Conclusions
This study has found that older adults trust their family doctor and they follow 
their advice regarding vaccine receipt. Older adults’ knowledge about vaccines is limited. 
While vaccine receivers believe that the vaccine is effective, non-receivers have faith in 
the resiliency of their immune systems.
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